CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 96 filers reported holding CYTOSORBENTS CORP in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,047 | -48.4% | 51,621 | -1.5% | 0.00% | – |
| Q2 2023 | $188,181 | +6.1% | 52,418 | -0.4% | 0.00% | – |
| Q1 2023 | $177,366 | +114.9% | 52,631 | -1.1% | 0.00% | – |
| Q4 2022 | $82,517 | +13.0% | 53,237 | -0.4% | 0.00% | – |
| Q3 2022 | $73,000 | -37.6% | 53,473 | 0.0% | 0.00% | – |
| Q2 2022 | $117,000 | -77.1% | 53,473 | -66.5% | 0.00% | – |
| Q1 2022 | $510,000 | -23.8% | 159,690 | 0.0% | 0.00% | – |
| Q4 2021 | $669,000 | -50.6% | 159,690 | -4.2% | 0.00% | – |
| Q3 2021 | $1,353,000 | +15.1% | 166,744 | +7.1% | 0.00% | – |
| Q2 2021 | $1,176,000 | -16.2% | 155,639 | -3.7% | 0.00% | – |
| Q1 2021 | $1,403,000 | -11.8% | 161,661 | -19.1% | 0.00% | – |
| Q4 2020 | $1,591,000 | +11.0% | 199,716 | +11.1% | 0.00% | – |
| Q3 2020 | $1,433,000 | -7.0% | 179,749 | +15.4% | 0.00% | – |
| Q2 2020 | $1,541,000 | +25.4% | 155,760 | -2.0% | 0.00% | – |
| Q1 2020 | $1,229,000 | +164.3% | 158,974 | +31.7% | 0.00% | – |
| Q4 2019 | $465,000 | -19.0% | 120,681 | +5.7% | 0.00% | – |
| Q3 2019 | $574,000 | -13.2% | 114,141 | +14.1% | 0.00% | – |
| Q2 2019 | $661,000 | -13.3% | 99,995 | -0.7% | 0.00% | – |
| Q1 2019 | $762,000 | -3.1% | 100,687 | +3.4% | 0.00% | – |
| Q4 2018 | $786,000 | -35.8% | 97,330 | +2.7% | 0.00% | – |
| Q3 2018 | $1,224,000 | +29.1% | 94,814 | +14.0% | 0.00% | – |
| Q2 2018 | $948,000 | +355.8% | 83,148 | +181.8% | 0.00% | – |
| Q1 2018 | $208,000 | +26.8% | 29,506 | +17.1% | 0.00% | – |
| Q4 2017 | $164,000 | +3.8% | 25,195 | -1.3% | 0.00% | – |
| Q3 2017 | $158,000 | +43.6% | 25,519 | 0.0% | 0.00% | – |
| Q2 2017 | $110,000 | -4.3% | 25,519 | -0.5% | 0.00% | – |
| Q1 2017 | $115,000 | -17.9% | 25,643 | 0.0% | 0.00% | – |
| Q4 2016 | $140,000 | -17.6% | 25,643 | -3.6% | 0.00% | – |
| Q3 2016 | $170,000 | +26.9% | 26,592 | -9.8% | 0.00% | – |
| Q2 2016 | $134,000 | +13.6% | 29,469 | -1.6% | 0.00% | – |
| Q1 2016 | $118,000 | +12.4% | 29,946 | +58.6% | 0.00% | – |
| Q4 2015 | $105,000 | -11.8% | 18,881 | 0.0% | 0.00% | – |
| Q3 2015 | $119,000 | +2.6% | 18,881 | 0.0% | 0.00% | – |
| Q2 2015 | $116,000 | -47.5% | 18,881 | +12.7% | 0.00% | – |
| Q1 2015 | $221,000 | – | 16,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |